title: Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo.
authors.forename: B
authors.initials: B
authors.lastname: Vander Cruyssen
authors.forename: F
authors.initials: F
authors.lastname: De Keyser
authors.forename: E
authors.initials: E
authors.lastname: Kruithof
authors.forename: H
authors.initials: H
authors.lastname: Mielants
authors.forename: F
authors.initials: F
authors.lastname: Van den Bosch
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D000069285:Infliximab; D007596:Joints / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab